Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats고양이에서 델타(B.1.617.2) 변이 바이러스의 실험적 수의사 SARS-CoV-2 백신 교차 중화Article Published on 2022-05-012022-09-11 Journal: Veterinary microbiology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody B.1.617.2 Canidae canine Canine vaccine Cat vaccine characterized comparable cross Delta delta variant epidemiological exhibited Felidae Hominidae immune response Mammalia mink Mink vaccine mounted Mutation neutralization neutralize novel Pathogenesis produced reduced reporter robust SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike protein SARS-CoV-2 vaccine SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 Wuhan strain serum Serum Neutralization Spike protein the SARS-CoV-2 Transmissibility Transmission vaccination Vaccine variant variant B.1.617.2 variety Veterinary vaccine virus Wuhan strain Zoetis Zoetis. [DOI] 10.1016/j.vetmic.2022.109395 PMC 바로가기 [Article Type] Article
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein TrimerArticle Published on 2022-02-172022-10-30 Journal: Marine Drugs [Category] COVID-19, COVID19(2023년), SARS, [키워드] Corallina officinalis Sargassum wightii ACE2 Alpha Alter Angiotensin-converting enzyme antibody antiviral drug B.1.1.529 BNT162b2 caffeic acid Compound compounds COVID-19 develop dietary supplement drug evade immunization infecting inhibit inhibitor inhibitory effect Interaction less manifested molecular docking analysis MOST mutated Mutation neutralization omicron omicron B.1.1529 Omicron variant Pathogenesis patients pharmacological phloretin PROTECT protein domains RBD receptor residue RMSD Sargassum SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants Screening seaweed Seaweeds severe disease spike spike glycoprotein suggested supported the receptor-binding domain therapeutic Transmissibility Transmission treat Treatment trimeric variant B.1.617.2 [DOI] 10.3390/md20020148 PMC 바로가기 [Article Type] Article
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination델타의 중화 감소 (B.1.617.2) 예방 접종 후 SARS-COV-2 우려 변형Research Article Published on 2021-12-022022-08-13 Journal: PLoS Pathogens [Category] Biochemistry, SARS, 변종, 진단, [키워드] (Beta accumulation African antibody Antibody titre antigenic antigenic drift antigenic profiles assessment Astra Zeneca Author B.1.351 B.1.617.1 B.1.617.2 bat bats Beta BNT162b2 BNT162b2 vaccines Booster vaccine booster vaccines ChAdOx1 changes in collected COVID-19 COVID19 death decrease decreases Delta delta variant dose effective Effectiveness Efficacy elicited evade expressed facilitate fold Fold changes glycoprotein groups hospitalisation Human human cell human cells humans Immunity India indicated individual Infection Lineage magnitude Mutation neutralisation neutralise Neutralising Antibodies neutralising antibody titres of BNT162b2 Pfizer Pfizer/BioNTech Prevent profile protective immune response pseudoviruses recipient recipients reduced reduction reduction in reductions reductions in required risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 virus sensitivity sera Severe infection shape significantly higher South South Africa spike glycoprotein spike glycoproteins Spike protein subsequent the spike protein titre vaccinated individuals vaccination Vaccine vaccine efficacy Vaccines variant variant B.1.617.2 variants variants of concern Viral viral variant Viral variants virus Virus spike VOCs while with infection with infections Wuhan Wuhan, China [DOI] 10.1371/journal.ppat.1010022 PMC 바로가기 [Article Type] Research Article
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India인도 델리에서 신흥 SARS-COV-2 변형의 게놈 특성 및 역학Article Published on 2021-10-222022-09-10 Journal: Science (New York, N.y.) [Category] Fulltext, MERS, 변종, 유전자 메커니즘, [키워드] (Alpha) antibody B.1.1.7 Bayesian city Cohort Combination Concentration contributed COVID-19 case COVID-19 cases Delta delta variant explain growth advantage immune response immune responses Immunity India median National outbreak reached reduced reduction replaced SARS-CoV-2 SARS-CoV-2 variant sensitivity Seropositivity Transmissibility variant variant B.1.617.2 [DOI] 10.1126/science.abj9932 PMC 바로가기 [Article Type] Article
Clinical features and laboratory findings first case of B. 1.617.2 (delta) variant concern (VOC) in IraqCase Report Published on 2021-09-042022-10-28 Journal: Annals of Medicine and Surgery [Category] COVID-19, [키워드] abdominal pain acute respiratory syndrome administration approach B.1.617.2 Blood clinical clinical feature Clinical features delta variant (VOC) Clinical finding coronavirus COVID-19 delta variant diagnosed with COVID-19 diarrhea Effectiveness COVID-19 vaccines feature female Fever globe Glucose headache India initial Iraq Laboratory leukocyte lockdown loss of appetite Mental mutated Patient Platelets Prevent reduce reported resulting RT-PCR SARS CoV-2 SARS-CoV-2 social distancing sore Spread treated United Kingdom variant variant B.1.617.2 Variant concern (VOC) variants Ventilation virus VoC vomiting WBC Wuhan, China [DOI] 10.1016/j.amsu.2021.102814 PMC 바로가기 [Article Type] Case Report
Genetic emergence of B.1.617.2 in COVID-19Correspondence Published on 2021-09-012022-10-05 Journal: New Microbes and New Infections [Category] 유전자 메커니즘, [키워드] SARS-CoV-2 approaches B.1.617.2 COVID-19 COVID-19 pandemic delta variant global initiative on sharing all influenza data (GISAID) India Indian SARS-CoV-2 consortium on genomics (INSACOG) pandemic Prevent Research Spread the SARS-CoV-2 vaccination variant B.1.617.2 [DOI] 10.1016/j.nmni.2021.100929 [Article Type] Correspondence
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumArticle Published on 2021-08-052022-10-31 Journal: Cell [Category] COVID-19, MERS, SARS, [키워드] Abstract acute respiratory syndrome Alpha analysis antibody antigenic B.1.1.7 B.1.351 B.1.617 B.1.617.1 B.1.617.2 binding domain both virus complement Complexes contributed convalescent convalescent serum coronavirus delta variant dominant escape Evidence immunization Indian subcontinent individual Infection Lineage lineages monoclonal antibody neutralization neutralize non-immune observation P.1 populations PROTECT provide RBD Receptor-binding-domain reduced reduction in Reinfection SARS-CoV-2 sera serological Strains Structure susceptible Transmissibility United Kingdom Vaccine variant variant B.1.617.2 variants widespread [DOI] 10.1016/j.cell.2021.06.020 PMC 바로가기 [Article Type] Article